Reduced perception of urgency in treatmentof overactive bladder with extended-release tolterodine

Author： Freeman R.   Hill S.   Millard R.   Slack M.   Sutherst J.   Tolterodine Study Group  

Publisher： Elsevier

ISSN： 0029-7844

Source： Obstetrics and Gynecology, Vol.102, Iss.3, 2003-09, pp. : 605-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

By Jacquetin B.   Wyndaele J.-J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 98, Iss. 1, 2001-09 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

Management of refractory overactive bladder

By Carmel Maude E   Goldman Howard B  

Expert Review of Obstretrics and Gynecology, Vol. 7, Iss. 6, 2012-11 ,pp. : 605-613

Informa Healthcare

Access to resources Recommend Favorite

Solifenacin for overactive bladder in women unsuccessfully treated with immediate release oxybutynin: A pilot study

By Wong C.   Duggan P.  

Journal of Obstetrics & Gynaecology, Vol. 29, Iss. 1, 2009-01 ,pp. : 31-34

Informa Healthcare

Access to resources Recommend Favorite

The efficacy of bladder distention therapy in the treatment of frequency and urgency

By Liapis A.   Bakas P.   Creatsas G.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 95, Iss. 1, 2001-03 ,pp. : 97-99

Elsevier

Access to resources Recommend Favorite

Transdermal oxybutynin: topical therapy for overactive bladder syndrome

By Wagg Adrian  

Expert Review of Obstretrics and Gynecology, Vol. 3, Iss. 2, 2008-03 ,pp. : 175-179

Informa Healthcare

Access to resources Recommend Favorite